Latest Us Market News

Actinogen Medical has reached a pivotal agreement with the US FDA outlining the regulatory and clinical trial requirements for Xanamem’s approval in Alzheimer’s disease, setting a clear path toward a US marketing application.

Medicare contractor Novitas plans to convene an expert panel in early 2026 to review coverage for Pacific Edge’s Cxbladder Triage test following the 2025 update to the American Urological Association microhematuria guideline.

St George Mining has formed a strategic alliance with US-based REAlloys Inc to advance the commercialisation of rare earths from the Araxá Project in Brazil, positioning itself within the growing US rare earths supply chain.

Stakk Limited has renewed its key contract with New York fintech Current Financial, locking in $280,000 in annual recurring revenue and reinforcing its foothold in the US embedded finance market.

Talga Group has signed a strategic cooperation agreement with United Catalyst Corporation, marking its entry into the US battery anode market and setting the stage for new graphite recycling and anode production facilities in South Carolina.

Cobram Estate Olives has secured $175 million through an institutional placement to accelerate its expansion in the US, aiming to increase its Californian olive groves to 3,600 hectares and boost olive oil production significantly by 2027.

Orthocell Limited reports an 81.1% overall treatment success rate from its Remplir Real World Evidence study, reinforcing the product’s safety and efficacy as it expands sales in the US and prepares regulatory submissions for the EU and UK.

SenSen Networks has secured $2 million in new contracts across Singapore, the USA, and Australia, reinforcing its position as a leader in Live Awareness AI solutions. The company also strengthened its balance sheet with $1.5 million cash received from a recent Montreal project.

Prophecy International flags higher churn and softer US sales for its Snare product, prompting a conservative FY2026 outlook and $3.2 million in annual cost savings.

Austal Limited secures a significant US$314 million contract option from the US Coast Guard, advancing the Offshore Patrol Cutter program with orders for three additional vessels.

The Calmer Co. reports a significant operational turnaround in H2 FY25, with sales momentum building through July and August, driven by cost reductions and new product launches in the US market.

4DMedical has won a crucial US Medicare reimbursement for its CT, VQ™ lung imaging software, paving the way for rapid adoption across American hospitals. This milestone follows FDA clearance and promises to transform lung diagnostics with safer, faster scans.